Table 1.
Clinical characteristics of patients in the low, intermediate, and high transcriptomic risk groups
| Characteristic | Transcriptomic risk group | ||
|---|---|---|---|
|
| |||
| Low (n = 41) | Intermediate (n = 121) | High (n = 41) | |
| Age at diagnosis, years | |||
| Median | 47 | 45 | 48 |
| Range | 28-80 | 21-79 | 20-79 |
| Stage, n (%) | |||
| I | 26 (25.5) | 58 (56.9) | 18 (17.6) |
| II | 6 (12.0) | 35 (70.0) | 9 (18.0) |
| III | 7 (21.9) | 17 (53.1) | 8 (25.0) |
| IV | 0 (0) | 8 (57.1) | 6 (42.9) |
| Unknown | 2 (40.0) | 3 (60.0) | 0 (0) |
| LN status, n (%) | |||
| Negative | 18 (23.4) | 47 (61.0) | 12 (15.6) |
| Positive | 12 (29.3) | 24 (58.5) | 5 (12.2) |
| Unknown | 11 (12.9) | 50 (58.8) | 24 (28.2) |
| OS, years | |||
| Median | NYR | 8.48 | 1.56 |
| Grade, n (%) | |||
| 1 | 4 (40.0) | 5 (50.0) | 1 (10.0) |
| 2 | 22 (22.9) | 56 (58.3) | 18 (18.8) |
| 3 | 13 (17.1) | 48 (63.2) | 15 (19.7) |
| 4 | 0 (0) | 1 (100) | 0 (0) |
| Unknown | 2 (10.0) | 11 (55.0) | 7 (35.0) |
NYR, not yet reached.